Skip to main content
Daniel Brennan, MD, Nephrology, Baltimore, MD, Johns Hopkins Hospital

DanielBrennanMD

Nephrology • Baltimore, MD

Kidney & Pancreas Transplantation

Medical and Co-Director, Comprehensive Transplant Center, Johns Hopkins

Join to view full profile

Dr. Brennan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brennan's full profile

Already have an account?

Summary

  • Dr. Daniel Brennan is a nephrologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from University of Iowa Carver College of Medicine and has been in practice 31 years. He specializes in kidney & pancreas transplantation and is experienced in general nephrology, transplant nephrology, and dialysis.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital
    Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1988 - 1992
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1985 - 1988
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1985
  • Cornell College
    Cornell CollegeBS, Magna Cum Laude with Distinction in Chemistry, 1977 - 1981

Certifications & Licensure

  • DE State Medical License
    DE State Medical License 2022 - 2025
  • MD State Medical License
    MD State Medical License 2017 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • MO State Medical License
    MO State Medical License 1993 - 2019
  • IA State Medical License
    IA State Medical License 1985 - 2001
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2004
  • AST Senior Achievement in Clinical Transplantation Award 2016
  • America's Top Doctors Castle Connolly, 2005-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Complete genome sequence of BK polyomavirus subtype Ib-1 detected in a kidney transplant patient with BK viremia using shotgun sequencing  
    Ranjan R, Rani A, Brennan DC, Finn PW, Perkins DL, Genome Announcements, 1/1/2017
  • Single-dose rituximab for recurrent glomerulonephritis post-renal transplant  
    Spinner ML, Bowman LJ, Horwedel TA, Delos Santos RB, Klein CL, Brennan DC, Am J Nephr, 1/1/2015
  • Safety events in kidney transplant recipients: Results from the folic acid for vascular outcome reduction in transplant trial  
    Weir MR, Gravens-Muller L, Costa N, Ivanova A, Manitpisitkul W, Bostom AG, Diamantidis CA, FAVORIT Study Investigators, Transplantation, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • eLS 
    Chapter: Polyomavirus infections of humans 
    Java A, Cheng X, Brennan DCJohn Wiley and Sons, Ltd, Chichester2012
  • Core Concepts in Renal Transplantation 
    Chapter: Infectious Complications in Renal Transplant Recipients 
    Page 179.0 - 210.0Dubberke ER, Brennan DCEditors: Chandraker A, Sayegh MH, Singh AK.Springer Science + Business Media, LLC, New York, NY2012
  • Acute Rejection: Risk Factors, Management and Complications 
    Chapter: Presentation, diagnosis and treatment of acute rejection 
    Page 131.0 - 149.0Hardinger KL, Brennan DCEditors: Kobayashi T and Arai R.NOVA Publishers, Hauppauge, NY2012
  • Join now to see all

Abstracts/Posters

  • A novel methodology to determine and compare transplant costs for renal recipients
    Brennan DC, American Transplant Congress, Toronto, Canada, 1/1/2008
  • Novel approach to obtain long-term outcomes of patients in a randomized trial comparing Thymoglobulin and Basiliximab in kidney transplant using registry data
    Brennan DC, Willoughby LM, Buchanan PM, Dzebisashvili N, Ercole P, Schnitzler MA, Am J Transplantation, American Transplant Congress, San Francisco, CA, 1/1/2007
  • Two-hour post-dose cyclosporine level may not predict nephrotoxicity in kidney transplantation recipients
    Brennan DC, XIX International Congress, Miami, FL, 1/1/2002
  • Join now to see all

Lectures

  • Immunosuppressive Management in Acute Infections and Malignancy in Renal Transplantation 
    Boston, MA - 1/1/2017
  • Overview of Renal Transplant Rejection – Pathology, Diagnosis, Treatment and Outcomes 
    Boston, MA - 1/1/2017
  • BK Virus – Prevention and Treatment 
    Chicago, IL - 1/1/2017
  • Join now to see all

Other

Press Mentions

  • CAR T-cell Therapy Neurotoxicity Linked to NfL Elevations
    CAR T-cell Therapy Neurotoxicity Linked to NfL ElevationsOctober 3rd, 2022
  • Vera Therapeutics : ATC 2022 Presentation
    Vera Therapeutics : ATC 2022 PresentationJune 6th, 2022
  • Vera Therapeutics Reports Positive Interim Phase 2 Data Showing MAU868 Has Significant BK Antiviral Activity in Kidney Transplant Patients
    Vera Therapeutics Reports Positive Interim Phase 2 Data Showing MAU868 Has Significant BK Antiviral Activity in Kidney Transplant PatientsJune 4th, 2022
  • Join now to see all

Grant Support

  • Polyomavirus And Mentoring In Renal TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2012
  • Modification Of "Edmonton Protocol" To Allow Successful Islet TransplantationNational Center For Research Resources2004–2006
  • Targeting The IL-2 Receptor In DiabetesNational Institute Of Allergy And Infectious Diseases1988–1990

Professional Memberships

Hospital Affiliations

Dr. Daniel Brennan, Dr. Daniel Brennan, MD, Dr. D Brennan